SEC Form 4 · accession 0001415889-15-002684
ACADIA PHARMACEUTICALS INC · ACAD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lester J Ph D Kaplan
Director
Period of report
Aug 11, 2015
Accepted (ET)
Aug 13, 2015 · 5:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070494
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 11, 2015 | M | 8,500 | $11.00 | A | 17,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $11.00 | Aug 11, 2015 | M | 8,500 | D | — | Sep 8, 2015 | Common Stock | 8,500 | 0 | D |
Explanation of responses
- F125% of the shares subject to the Stock Option vested and became exercisable at the end of each 3-month period following the date of grant of September 9, 2005.